AI assistant
AtriCure, Inc. — Director's Dealing 2020
Jan 21, 2020
31802_dirs_2020-01-21_faecb9d6-e4b6-4548-a1f2-664753eaa29d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2020-01-17
Reporting Person: Seith Douglas J (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-01-17 | Common Stock | M | 38000 | $6.73 | Acquired | 147772 | Direct |
| 2020-01-17 | Common Stock | F | 15090 | $38.00 | Disposed | 129182 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-01-17 | Stock Option (Right to buy) | $6.73 | M | 38000 | Disposed | 2022-12-27 | Common Stock (38000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3500 | Indirect |
Footnotes
F1: These shares were exercised pursuant to a 10b5-1 trading plan.
F2: These shares were sold pursuant to a 10b5-1 trading plan.
F3: The Reporting Person disclaims beneficial ownership of these securities, except as to his pecuniary interest therein.
F4: These options were granted on December 27, 2012. The options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.